BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 25538169)

  • 1. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
    Gilchrist M; Seaton RA
    J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement.
    Patel S; Abrahamson E; Goldring S; Green H; Wickens H; Laundy M
    J Antimicrob Chemother; 2015 Feb; 70(2):360-73. PubMed ID: 25331058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.
    Chapman AL; Seaton RA; Cooper MA; Hedderwick S; Goodall V; Reed C; Sanderson F; Nathwani D;
    J Antimicrob Chemother; 2012 May; 67(5):1053-62. PubMed ID: 22298347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient parenteral antibiotic therapy: principles and practice.
    Seaton RA; Barr DA
    Eur J Intern Med; 2013 Oct; 24(7):617-23. PubMed ID: 23602223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient parenteral antimicrobial therapy: updated recommendations from the UK.
    Chapman ALN; Patel S; Horner C; Gilchrist M; Seaton RA
    J Antimicrob Chemother; 2019 Nov; 74(11):3125-3127. PubMed ID: 31504575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history and evolution of outpatient parenteral antibiotic therapy (OPAT).
    Williams DN; Baker CA; Kind AC; Sannes MR
    Int J Antimicrob Agents; 2015 Sep; 46(3):307-12. PubMed ID: 26233483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
    Sumpter C; Russell CD; Mackintosh C
    Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.
    Barr DA; Semple L; Seaton RA
    Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent innovations and new applications of outpatient parenteral antimicrobial therapy.
    Farmer ECW; Seaton RA
    Expert Rev Anti Infect Ther; 2021 Jan; 19(1):55-64. PubMed ID: 32799577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service.
    Gilchrist M; Franklin BD; Patel JP
    J Antimicrob Chemother; 2008 Jul; 62(1):177-83. PubMed ID: 18408239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis.
    Jones GR; Cumming DV; Honeywell G; Ball R; Sanderson F; Seaton RA; Healy B; Hedderwick S; Gilchrist M;
    J Antimicrob Chemother; 2015 Apr; 70(4):1236-40. PubMed ID: 25558074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient parenteral antimicrobial therapy today.
    Paladino JA; Poretz D
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
    Shah PJ; Bergman SJ; Graham DR; Glenn S
    J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
    Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
    J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A practical program for outpatient parenteral antimicrobial therapy].
    Ravelingien T; Buyle F; Deryckere S; Huis In 't Veld D; Debrauwere M; Verplancke K; Callens S; Commeyne S; Pattyn C; Somers A; Vogelaers D
    J Pharm Belg; 2016 Sep; (3):22-31. PubMed ID: 30281241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London service.
    Hatcher J; Costelloe C; Cele R; Viljanen A; Samarasinghe D; Satta G; Brannigan E; De Barra E; Sanderson F; Gilchrist M
    Int J Antimicrob Agents; 2019 Aug; 54(2):207-214. PubMed ID: 30986525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade.
    MacKenzie M; Rae N; Nathwani D
    Int J Antimicrob Agents; 2014 Jan; 43(1):7-16. PubMed ID: 24200469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.